This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit August 27, 2014

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Storied breast cancer drug Avastin gets another use: cervical cancer
Healthline
The anti-cancer drug bevacizumab, or Avastin, added recurrent and metastatic cervical cancer to its list of approved uses. Cervical cancer, usually caused by the sexually transmitted human papillomavirus, can be stopped if it's caught early, but it can progress in women who don't get regular cervical exams. Once the cancer spreads, or metastasizes, survival rates dip below one in six. More than 12,000 Americans will likely be diagnosed with cervical cancer in 2014, and one-third are expected to die from the disease.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


New Career Pathways page added
ASCT
In response to comments and requests from the recent ASCT Membership Survey, the PR Committee has added a new public page to the ASCT website containing information on Cytotechnology Career Pathways. The page offers general information on new opportunities, comprehensive molecular resources, and detailed information on specific areas such as UroVysion, Her2 testing and circulating tumor cells. The page is located under the Resources tab. The PR committee will continue to add content when appropriate. If you have a resource that you would like to share, please contact: SNGiroux@gmail.com.

Click "Read More" to visit the new Career Pathways page.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


UPCOMING EVENTS

Date Event Location More information
Sept. 18
2 p.m. EST
Skills and Tools Required to be a Good Laboratory Manager Your PC
Anil R. Prasad, M.D., Associate Professor, Department of Pathology at the University of Arizona Health Science Center in Tucson, Arizona.
More info | Register
Oct. 8
2 p.m. EST
How to Stand out in a Crowd: Differentiating Hyperchromatic Crowded Groups (HCGs) Your PC

Donna Russell, M.Ed., CT(ASCP) HT, Education Coordinator, Cytopathology
Residency / Fellowship Program, University of Rochester Medical Center, Rochester, New York
More info | Register
Oct. 21-22 Northeast Laboratory Conference Portland, Maine
Holiday Inn By The Bay
207-775-2311 or 800-345-5070
Details

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


Avoiding the HPV vaccine for your kids? Maybe it's time to reconsider
Tampa Bay Times
If you have an adolescent son or daughter, you might be wrestling with a big question: Whether to get your child the HPV vaccine. Unlike other vaccines, this one isn't a requirement to go to school, and a lot of Florida parents are declining it. In fact, we have the second-worst HPV vaccination rate in the nation. Just a quarter of girls ages 13 to 17 (and even fewer boys) have received all three doses of the vaccination needed to protect against the human papillomavirus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV vaccine protects against infection 8 years out
HealthDay via WebMD
A new long-term study shows that the human papillomavirus vaccine appears to protect against the sexually transmitted virus for at least eight years. HPV is thought to cause the majority of cervical cancers. Certain strains, such as HPV 16 and 18, are most strongly tied to these tumors. The virus is also believed to cause genital warts in both men and women and certain head and neck cancers. Among the vaccinated preteens in the new study, none developed any of the diseases or conditions associated with HPV during the study period, the researchers reported.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Melissa Mark-Viverito: Getting tested early and often will help detect HPV
New York Daily News
"I thought about keeping this to myself. But I know that suffering in silence is not healthy. And speaking up — especially when there is so much stigma and judgment around HPV — could be important for other women and men who are affected by this virus. I am a private person, but I think it is a role of those of us who are public figures to destigmatize. Some may say it's too much information; I would say it's necessary information," said Melissa Mark-Viverito, Speaker of the New York City Council.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


Test could detect HPV-related head and neck cancer recurrence
Cancer Network
Researchers at Johns Hopkins University have developed a preliminary test using plasma and saliva samples to detect recurrence in patients with human papillomavirus-related head and neck squamous cell carcinoma. The study was published in JAMA Otolaryngology–Head & Neck Surgery.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The growing threat of antibiotic resistance
By Rosemary Sparacio
A number of diseases once easily treatable have become resistant to antibiotics currently on the market, and that number continues to grow. Tom Frieden, director of the Centers for Disease Control and Prevention, has warned that antibiotic resistance is such a serious problem that it could be the "next pandemic." Obviously, the growth of antibiotic-resistant pathogens means that more and more cases emerge where standard treatments no longer work, infections become more difficult to control, and the risk of spreading infections to others is increased — especially when hospital stays are prolonged.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword ANTIBIOTIC


New research will help detect ovarian cancer earlier, aid in personalized treatment
Medical Daily
Ovarian cancers are among the most difficult cancers to diagnose and treat. There are no early stage diagnostics for ovarian cancer and by the time they are discovered, they may not respond to standard cancer treatments. But a new research from A*STAR's Institute of Medical Biology and the Bioinformatics Institute have found new clues to early detection and personalized treatments of ovarian cancer, thus offering hope to millions of women who might be susceptible to it. Their findings were published online in Nature Cell Biology in July 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Aug. 13, 2014
July 23, 2014
July 9, 2014
June 25, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063